Pfizer SG&A Expense (TTM) Trends

Pfizer Inc (PFE)

25.26 -1.01 (-3.84%) USD | NYSE | Apr 25, 16:00

25.40 +0.14 (+0.55%) Pre-Market: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1990. Upgrade now.

Date	Value
December 31, 2023	14.77B
September 30, 2023	14.84B
June 30, 2023	14.95B
March 31, 2023	14.50B
December 31, 2022	13.68B
September 30, 2022	13.14B
June 30, 2022	12.64B
March 31, 2022	12.52B
December 31, 2021	12.70B
September 30, 2021	12.34B
June 30, 2021	12.10B
March 31, 2021	11.83B
December 31, 2020	11.60B
September 30, 2020	10.47B
June 30, 2020	11.08B
March 31, 2020	11.93B
December 31, 2019	12.73B
September 30, 2019	12.27B
June 30, 2019	12.51B
March 31, 2019	12.54B
December 31, 2018	12.61B
September 30, 2018	15.00B
June 30, 2018	15.01B
March 31, 2018	14.90B
December 31, 2017	14.80B

Date	Value
September 30, 2017	14.68B
June 30, 2017	14.73B
March 31, 2017	14.78B
December 31, 2016	14.84B
September 30, 2016	15.46B
June 30, 2016	15.17B
March 31, 2016	15.09B
December 31, 2015	14.81B
September 30, 2015	13.74B
June 30, 2015	14.03B
March 31, 2015	14.16B
December 31, 2014	14.10B
September 30, 2014	14.27B
June 30, 2014	14.11B
March 31, 2014	14.18B
December 31, 2013	14.36B
September 30, 2013	14.54B
June 30, 2013	14.64B
March 31, 2013	14.71B
December 31, 2012	15.46B
September 30, 2012	15.07B
June 30, 2012	16.04B
March 31, 2012	17.17B
December 31, 2011	17.71B
September 30, 2011	18.96B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

10.47B

Minimum

Sep 2020

14.95B

Maximum

Jun 2023

12.77B

Average

12.52B

Median

Mar 2022

SG&A Expense (TTM) Benchmarks